NewCelX Ltd. (Form 6-K Summary)

Date: November 3, 2025

• **Material Event: ** NewCelX Ltd. reported the closing of its merger with NLS Pharmaceutics Ltd.
• Following the transaction, the Company issued a Business and Strategic Roadmap Update.
• Investors should review the furnished Exhibit 99.1 (Press Release) and Exhibit 99.2 (Investor Presentation) for details on the combined entity’s strategy.
• The filing was certified by CEO Ronen Twito.

This filing primarily provides public notice and supporting documents for the recently completed corporate combina